Navigation Links
ATS Medical Products Featured Prominently in Scientific Presentations at European Association for Cardio-Thoracic Surgeons (EACTS) Annual Meeting
Date:9/11/2008

ssue valve that operates unlike any other valve. Like a native aortic valve that functions as a tubular structure whose sides collapse in response to pressure, the proprietary tubular valve design of the ATS 3f Aortic Bioprosthesis reproduces the functional characteristics of a native aortic valve, resulting in more normal distribution of stress on the valve leaflets and laminar, non-turbulent trans-prosthetic flow that is indistinguishable from flow across the normal valve. With more than six years of clinical experience to date confirming excellent safety and efficacy, the combination of normal blood flow dynamics and improved stress distribution offered by the ATS 3f Aortic Bioprosthesis provides surgeons and patients a potentially more durable and physiologic solution to aortic valve replacement. The ATS 3f Aortic Bioprosthesis will be the focus of an EACTS Satellite Symposium on September 16th entitled, "The ATS 3f(R) Revolution" that will be moderated by Dr. James Cox, ATS Medical Director.

The ATS CryoMaze Clamp is the only ablation clamp that offers visible transmurality and allows for safe and effective concomitant ablation in coronary artery bypass graft and aortic procedures using a single device and energy source. The entire ATS CryoMaze product line will be the center of discussions at the ATS Medical Symposium on September 15th entitled "Frontiers In Cryoablation Symposium: The Rationale for Lesion Patterns and Cryosurgery." Ablation therapy is expected to be a key growth driver for the company in 2009.

The ATS Open Pivot(R) Mechanical Heart Valves will be highlighted during an in-booth presentation entitled "Anticoagulation of Mechanical Valves and Our ATS Open Pivot Experience" by Professor Guido Van Nooten on Tuesday, September 16th at 10:45 AM.

The ATS Simulus(R) Semi Rigid Annuloplasty Ring, the newest addition to the company's expanding line of mitral valve repair prosthetics, will also be introduced to the European marketpla
'/>"/>

SOURCE ATS Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. MSU engineering team designs innovative medical device
2. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
4. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
5. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
6. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
7. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
8. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
9. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
10. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
11. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:New Research Shows a Vitamin/Nutriceutical Formulation Improves Memory and Cognitive Performance in Community-Dwelling Adults 2Merieux Alliance Becomes Institut Merieux 2Merieux Alliance Becomes Institut Merieux 3Merieux Alliance Becomes Institut Merieux 4European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis 2USC researchers present diabetes findings at American Diabetes Association Scientific Sessions 8730 1USC researchers present diabetes findings at American Diabetes Association Scientific Sessions 8730 2CEL SCI Collaborators Demonstrate Novel L E A P S Vaccines Immunize Mice Against Tuberculosis Antigens and Suggest Potential to Treat Swine and Other 4539 1CEL SCI Collaborators Demonstrate Novel L E A P S Vaccines Immunize Mice Against Tuberculosis Antigens and Suggest Potential to Treat Swine and Other 4539 2CEL SCI Collaborators Demonstrate Novel L E A P S Vaccines Immunize Mice Against Tuberculosis Antigens and Suggest Potential to Treat Swine and Other 4539 3Some OTC Sleep Cold Meds Could Harm Aging Brain 48044 1Some OTC Sleep Cold Meds Could Harm Aging Brain 48044 2Some OTC Sleep Cold Meds Could Harm Aging Brain 48044 3